Clinical Trial, Phase II
Showing 1 - 25 of >10,000
Sleep Initiation and Maintenance Disorders Trial (QUALI)
No longer available
- Sleep Initiation and Maintenance Disorders
- (no location specified)
Feb 23, 2023
Alzheimer Trial in Houston (Interleukin-2, Placebo)
Recruiting
- Alzheimer Disease
- Interleukin-2
- Placebo
-
Houston, TexasHouston Methodist Research Institute
Oct 17, 2023
Hand, Foot and Mouth Disease, Herpangina Trial in Chuxiong (low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated,
Recruiting
- Hand, Foot and Mouth Disease
- Herpangina
- low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated
- +3 more
-
Chuxiong, Yunnan, ChinaDayao County Center for Disease Control and Prevention
Sep 25, 2023
Rotavirus Infections, Diarrhea Trial (IRV on a 0- and 28-day schedule, IRV on a 0-, 28- and 56-day schedule, Placebo on Day 0,
Not yet recruiting
- Rotavirus Infections
- Diarrhea
- IRV on a 0- and 28-day schedule
- +3 more
- (no location specified)
Oct 8, 2023
NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Phase I - Mirdametinib - Level 1
- +4 more
- (no location specified)
Jul 7, 2023
Seminoma Trial in Duesseldorf (Robot-assisted retroperitoneal lymph node dissection, Adjuvant therapy with one cycle of
Recruiting
- Seminoma
- Robot-assisted retroperitoneal lymph node dissection
- Adjuvant therapy with one cycle of cisplatin, etoposide and bleomycin
-
Duesseldorf, GermanyUniversity Hospital of Duesseldorf
Nov 17, 2023
Stage II Melanoma Trial in Wollstonecraft (Relatlimab and nivolumab fixed dose combination (FDC))
Not yet recruiting
- Stage II Melanoma
- Relatlimab and nivolumab fixed dose combination (FDC)
-
Wollstonecraft, New South Wales, AustraliaMelanoma Institute Australia
Oct 26, 2022
SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA Vaccine
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023
Peritoneal Metastases, Colorectal Cancer Trial in Hangzhou (Hyperthermic intraperitoneal treatment of recombinant modified human
Recruiting
- Peritoneal Metastases
- Colorectal Cancer
- Hyperthermic intraperitoneal treatment of recombinant modified human tumor necrosis factor (rmhTNF)
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Mar 2, 2023
Osteosarcoma Trial (Tucidinostat, Apatinib)
Not yet recruiting
- Osteosarcoma
- Tucidinostat, Apatinib
- (no location specified)
Nov 5, 2023
Non-hodgkin Lymphoma Trial (HY004)
Not yet recruiting
- Non-hodgkin Lymphoma
- HY004
- (no location specified)
Aug 21, 2023
Advanced Malignant Tumors Trial in China (LBL-033 for Injection)
Not yet recruiting
- Advanced Malignant Tumors
- LBL-033 for Injection
-
Fuzhou, Fujian, China
- +5 more
Mar 19, 2023
Malignant Sarcoma Trial in Madrid (Natural Killer (NK) cells (a new immunotherapy))
Recruiting
- Malignant Sarcoma
- Natural Killer (NK) cells (a new immunotherapy)
-
Madrid, SpainHospital Universitario La Paz
Jul 19, 2023
Hamstring Injury Trial in Pittsburgh (Losartan, )
Recruiting
- Hamstring Injury
- Losartan
- placebo
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Dec 14, 2022
Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)
Not yet recruiting
- Hepatic Ascites
- Recombinant Human Serum Albumin
- Human serum albumin
-
Guangdong, Shenzhen, ChinaShenzhen Protgen Ltd
May 5, 2023
Pompe Disease (Late-onset) Trial in Durham (Clenbuterol, Placebos)
Withdrawn
- Pompe Disease (Late-onset)
- Clenbuterol
- Placebos
-
Durham, North CarolinaDuke University Medical Center
Aug 15, 2022
Non Small Cell Lung Cancer Trial (HLX208+HLX10)
Not yet recruiting
- Non Small Cell Lung Cancer
- HLX208+HLX10
- (no location specified)
Nov 30, 2022
Hidradenitis Suppurativa Trial in Granada (Injectable suspension of allogeneic adult mesenchymal stem cells, Placebo)
Recruiting
- Hidradenitis Suppurativa
- Injectable suspension of allogeneic adult mesenchymal stem cells
- Placebo
-
Granada, SpainHospital Universitario Virgen de Las Nieves
Jul 6, 2023
Ventricular Tachycardia Trial in Zürich (Dose escalating stereotactic arrhythmia radioablation to treat ventricular tachycardia
Recruiting
- Ventricular Tachycardia
- Dose escalating stereotactic arrhythmia radioablation to treat ventricular tachycardia (VT)
-
Zürich, Zurich, SwitzerlandUniversity Hospital Zurich
Oct 21, 2022
Amyotrophic Lateral Sclerosis Trial (Acetyl-l-carnitine, Placebo)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- Acetyl-l-carnitine
- Placebo
- (no location specified)
Nov 9, 2023
Overweight or Obesity Trial in Uppsala (Xenical® vs EMP 22, EMP 22 vs Xenical®, EMP 16 vs Xenical®)
Not yet recruiting
- Overweight or Obesity
- Xenical® vs EMP 22
- +2 more
-
Uppsala, SwedenCTC Clinical Trial Consultanta AB
Aug 25, 2023